NCT00995345View on ClinicalTrials.gov

Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

PHASE2CompletedINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Type 2 Diabetes
Interventions
DRUG

KRP-104

Tablet

DRUG

Placebo

Tablet

Trial Locations (45)

Unknown

Birmingham

Phoenix

Los Angeles

Valley Village

Honolulu

Winston-Salem

Cincinnati

Delaware

Marion

Beaver

Jenkintown

Greer

Austin

Houston

San Antonio

Sandy City

West Jordan

Buenos Aires

Córdoba

Loma Hermos Buenos Aires

Chrudim III

Holešov

Mělník

Ostrava

Prague

Guatemala City

Bialystok

Gdansk

Krakow

Lodz

Warsaw

Wroclaw

Arkhangelsk

Kemerovo

Moscow

Novosibirsk

Saint Petersburg

Port Elizabeth

Bloemfontein

Johannesburg

Soweto

Durban

Cape Town

Paarl

Somerset West

Sponsors
All Listed Sponsors
collaborator

Kyorin Pharmaceutical Co.,Ltd

INDUSTRY

lead

ActivX Biosciences, Inc.

INDUSTRY

NCT00995345 - Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone | Biotech Hunter | Biotech Hunter